gemigliptin 50 mg and metformin hydrochloride 1000 mg prolonged release
Sponsors
LG Chem
Conditions
Type 2 DiabetesType2 Diabetes
Phase 1
Bioequivalence Study for Gemigliptin/Metformin 50/1000 mg and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.
NCT04050098
Start: 2019-11-01End: 2019-11-30Target: 24Updated: 2019-08-08
Bioequivalence Study for Fixed Dose Combination Zemimet® SR Tab. 50/1000 and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.
CompletedNCT04317703
Start: 2020-08-19End: 2020-09-05Updated: 2021-02-09